top of page
4-CYTE logo
students

BIOBRIDGE THERAPEUTICS

BioBridge Therapeutics is the translational arm of 4-CYTE– our internal biotech incubator that carries discoveries across the perilous “valley of death” between academia and the clinic. In BioBridge, promising research findings don’t sit idle; they are nurtured, developed, and propelled toward therapies. This unit operates like a startup but within the safe confines of a supportive university, pushing forward preclinical studies, drug development, and prototype testing with the rigor and urgency found in industry.

Neuroanatomical Dissection Course
Neuroanatomical Dissection Course

The Core Functions of BioBridge Therapeutics

  • BioBridge will advance groundbreaking clinical trials for novel treatments targeting substance use disorder, schizophrenia, depression, and trichotillomania. For each condition, the team:

    • Designs state-of-the-art clinical studies that integrate modern science, AI-driven precision medicine, and innovative trial methodologies to maximize trial success.

    • Builds academic-industry partnerships capable of executing each study

    • Submits competitive NIH grant proposals to fund each trial

  • Upon securing funding, BioBridge oversees these collaborations, ensuring the trials are conducted with scientific rigor and efficiency.

bottom of page